Drugdu.com expert's response:

In pharmaceutical foreign trade, after receiving an inquiry, the hardest part is often not figuring out how to reply, but determining which one deserves more of your time investment.

Some buyers only send a one-line message saying "Please send price", while others directly list product specifications, quantities and destination countries. There are also clients who, after two rounds of communication, start requesting COAs, Specifications, GMP documents, and even ask for samples. When several inquiries are laid out in front of you, the one with abundant information may not close a deal immediately, and the seemingly simple inquiry does not necessarily mean there is no procurement plan at all.

To judge whether an inquiry is worth following up on with priority, you can refer to several specific behavioral signals from the buyer.

Buyers asking about product details are usually more worthy of further exploration than those who only send a simple price request

When pharmaceutical procurement enters the stage of specific product communication, the buyer's questions will gradually become more granular.
Taking active pharmaceutical ingredients (APIs) as an example, purchasers may start to confirm the purity, impurity standards, pharmacopoeia standards, packaging specifications and production batch sizes. For medical device buyers, they may continue to inquire about product models, certification coverage, packaging methods, registration documents and delivery lead times.
All these questions share one common feature: the buyer is already matching your products against their own procurement requirements.
If suppliers only respond around the price at this stage, they will easily miss the opportunity to dig deeper into the project. You can follow up on the buyer's questions, and supplement the conversation by asking about the product's intended use, procurement phase, estimated quantity and target market.
For example, when a buyer requests the COA of a certain API, you can provide a sample of the document while adding this line:
"Could you also share your required specification and target market? We can check whether our current standard matches your project."
This way, you not only answer the buyer's question, but also obtain an extra layer of procurement information.

When buyers ask for documents, it is critical to identify what type of documents they are requesting

"Please send documents" may sound like a very ordinary request, but the documents different buyers ask for can vary greatly.
Some people only want the basic COA, some will go on to request the Specification, GMP certificate and DMF status, while others will explicitly ask for CEP, stability data, impurity profiles or registration-related documents.
The more specific the document requirements are, the more necessary it is for suppliers to confirm the intended use of the project.
For instance, if the buyer mentions "for registration", the subsequent communication should not only focus on MOQ and unit price. You also need to find out the target country, formulation project, planned submission timeline, and the level of registration support your company is able to provide.
It is also important to control the pace of document delivery. Basic product information can be provided in a timely manner, but content involving registration dossiers, process details and commercially sensitive information should be handled in accordance with the project phase and your company's internal policies. Sending all documents to the client in a full package at the very beginning will not make your communication look more professional.

A buyer's sample request is a positive signal, but it does not equal a confirmed order

Many salespeople will immediately put an inquiry at the highest priority as soon as they see the message "Can you send a sample?".
A sample request does represent a step further than ordinary browsing, but before arranging the shipment, you'd better get a few questions clarified: Is the sample used for testing, formulation research, or supplier screening? What quantity do they need? Which indicators will be tested? What is the expected purchase volume after the tests are passed? Who will be in charge of the subsequent procurement or registration work?
This set of information can help suppliers judge whether the sample is serving a clearly defined project, or the buyer is just conducting a preliminary screening by requesting samples from a large number of suppliers at the same time.
Especially for high-value raw materials, customized products or items with high sample preparation costs, one extra round of confirmation before sending out samples can greatly reduce ineffective resource investment.

To assess the quality of an inquiry, you can also check how much information the buyer is willing to share about themselves

Suppliers often worry that asking too many questions will "scare the client away". But in actual pharmaceutical procurement communication, both parties need to exchange information step by step.
As a procurement project moves forward, the buyer will usually start to share their own requirements, such as the target country, procurement quantity, application direction, quality standards and estimated timeline. Some will also clarify their identity: whether they are an end pharmaceutical factory, a distributor, a registration agent or a purchasing company.
If the supplier has successively provided quotations, certificates and samples, but the other party still refuses to disclose any details about the project, you should control the level of subsequent resource investment.
On the contrary, if the buyer is willing to make their requirements more and more specific, even if the order has not been confirmed at the moment, the client is still worth continuous follow-up and maintenance.

The product information on the platform can also help suppliers filter clients in advance

Many problems with inquiry quality actually occur before the buyer sends the first message.
If your product page only contains the product name, a picture and a brief introduction, buyers cannot confirm the specifications, certifications and supply capacity in advance, so the inquiries you receive will naturally stay at the superficial level of "Price?" or "Details?".
If your product page has clearly presented the CAS number, specifications, quality standards, packaging, certification status and the list of available documents, the buyers who choose to contact you afterwards will usually come with more specific questions.
After uploading the product, suppliers can go through a final check: Can a visitor who sees this page judge whether this product matches their project? What information is still missing for them, which has to be confirmed through an inquiry?
The more detailed this step is, the less time you will waste in the subsequent communication.

A high-priority inquiry usually becomes clearer gradually

The pharmaceutical procurement cycle is long, and many projects will not tell suppliers all the details including the quantity, budget and registration plan in the very first email.
A more practical way to evaluate the inquiry quality is to observe whether the communication is moving forward: Are the client's questions becoming more specific? Are they starting to verify the documents? Are they willing to state their target market? Are they proposing sample testing? Are they starting to discuss the quantity, delivery lead time and commercial terms?
Once these behaviors appear, suppliers can appropriately raise the follow-up priority, and coordinate the supporting resources for documents, quotations and internal teams.
When you have a large number of inquiries on hand, there is no need to distribute your time evenly. Identifying the clients who are already entering the specific project communication stage first is usually far more effective than repeatedly chasing every client who only sent a "Please send price" message.